Insider trade

Promis Neurosciences (PMN): Director bought ~$15K

Neil Cashman, Director at Promis Neurosciences, bought ~$15K of Promis Neurosciences shares.

~$15K
Approx. value · 15K sh @ $0.973: 17K
Holds after · shares reported

Traded: Feb 10, 2025
Filed: Feb 12, 2025

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Promis Neurosciences

For Promis Neurosciences, OQRO holds 3 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PMN page.

Other recent filings by Neil Cashman, Chief Scientific Officer

SEC Form 4 at Promis Neurosciences (PMN)Nov 3, 2026

The full history of Neil Cashman, Chief Scientific Officer is on the profile page.

How this filing works

Explore the data

Other disclosures at Promis Neurosciences

Everything OQRO holds on this company is on its PMN page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data